← All First Tracks Biotherapeutics, INC filings

First Tracks Biotherapeutics, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
TRAX
First Tracks Biotherapeutics, INC
Form 4: First Tracks Biotherapeutics Executive Receives Stock Grant
Benjamin Stone, Chief Business Officer of First Tracks Biotherapeutics, Inc., received 60,492 shares of common stock on August 2, 2026.
NASDAQ
TRAX
First Tracks Biotherapeutics, INC
Form 4: First Tracks Biotherapeutics Executive Receives Stock Grant
Paul F. Lizzul, Chief Medical Officer of First Tracks Biotherapeutics, Inc., received 60,492 shares of common stock on August 2, 2026.
NASDAQ
TRAX
First Tracks Biotherapeutics, INC
Form 4: First Tracks Biotherapeutics CEO Receives Stock Grant
Daniel Faga, President, CEO and a Director of First Tracks Biotherapeutics, Inc., received 193,576 shares of common stock on August 2, 2026.